Effect of Eleclazine (GS-6615) on Exercise Capacity in Subjects With Symptomatic Hypertrophic Cardiomyopathy
Public ClinicalTrials.gov record NCT02291237. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
Study Title: A Phase 2/3, Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Effect of GS-6615 on Exercise Capacity in Subjects With Symptomatic Hypertrophic Cardiomyopathy
Brief summary
Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.
The primary objective of this study was to evaluate the effect of eleclazine (GS-6615) on exercise capacity as measured by Peak oxygen uptake (VO2) achieved during cardiopulmonary exercise testing (CPET), in participants with symptomatic hypertrophic cardiomyopathy (HCM).
Study identification
- NCT ID
- NCT02291237
- Recruitment status
- Terminated
- Study type
- Interventional
- Phase
- Phase 2, Phase 3
- Enrollment
- 172 participants
Conditions and interventions
Conditions
Eligibility (public fields only)
- Age range
- 18 Years to 65 Years
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Feb 5, 2015 (Actual)
- Primary completion
- Jan 20, 2017 (Actual)
- Completion
- Feb 17, 2017 (Actual)
- Last update posted
- Sep 24, 2018
2015 – 2017
United States locations
- U.S. sites
- 26
- U.S. states
- 16
- U.S. cities
- 19
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Cedars-Sinai Heart Institute | Los Angeles | California | — | — |
| University of California Los Angeles | Los Angeles | California | — | — |
| Stanford University | Stanford | California | — | — |
| Yale New Haven Hospital | New Haven | Connecticut | — | — |
| Athens Regional Medical Center | Athens | Georgia | — | — |
| Northwestern Memorial Hospital | Chicago | Illinois | — | — |
| University of Iowa Hospitals and Clinics | Iowa City | Iowa | — | — |
| Brigham & Women's Hospital and Harvard Medical School | Boston | Massachusetts | — | — |
| Massachusetts General Hospital | Boston | Massachusetts | — | — |
| Tufts Medical Center | Boston | Massachusetts | — | — |
| Washington University School of Medicine | St Louis | Missouri | — | — |
| Morristown Medical Center | Morristown | New Jersey | — | — |
| Columbia University Medical Center/ New York Presbyterian | New York | New York | — | — |
| NYU School of Medicine Pediatrics | New York | New York | — | — |
| Duke Health Center at Southpoint | Durham | North Carolina | — | — |
| Oregon Health and Science University | Portland | Oregon | — | — |
| St. Luke's University Health Network | Bethlehem | Pennsylvania | — | — |
| University of Pittsburgh Medical Center | Pittsburgh | Pennsylvania | — | — |
| St. Thomas Research Institute | Nashville | Tennessee | — | — |
| Vanderbilt University Medical Center | Nashville | Tennessee | — | — |
| Houston Methodist Hospital | Houston | Texas | — | — |
| Texas Heart Institute | Houston | Texas | — | — |
| UT Southwestern Medical Center | Houston | Texas | — | — |
| University of Washington | Seattle | Washington | — | — |
| Marshfield Clinic Research Institute | Marshfield | Wisconsin | — | — |
| Medical College of Wisconsin | Milwaukee | Wisconsin | — | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
Non-U.S. locations
This page focuses on the U.S. directory. The official record also lists 20 non-U.S. sites.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT02291237, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Sep 24, 2018 · Synced Oct 21, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete public registry record, listed eligibility criteria, and available contact information for NCT02291237 live on ClinicalTrials.gov.